<div>References:</div><div>1. Rosai J, Dorfman RF. Sinus histiocytosis with massive
lymphadenopathy. A newly recognized benign clinicopathological entity.<i>Archives of pathology</i> . Jan 1969;87(1):63-70.</div><div>2. Haroche J, Abla O. Uncommon histiocytic disorders: Rosai-Dorfman,
juvenile xanthogranuloma, and Erdheim-Chester disease. <i>Hematology
American Society of Hematology Education Program</i> . 2015;2015:571-8.
doi:10.1182/asheducation-2015.1.571</div><div>3. Albini TA, Evans M, See R, Rao NA, Marback E, de Souza MM.
Rosai-Dorfman disease: isolated epibulbar masses in two adult patients.<i>Br J Ophthalmol</i> . 2005;89(2):241-243. doi:10.1136/bjo.2004.048256</div><div>4. de Souza Maciel Rocha Horvat N, Coelho CR, Roza LC, et al. Spectrum
of abdominal imaging findings in histiocytic disorders. <i>Abdominal
imaging</i> . Oct 2015;40(7):2738-46. doi:10.1007/s00261-015-0449-1</div><div>5. McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders.<i>Hematology American Society of Hematology Education Program</i> .
2004:283-96. doi:10.1182/asheducation-2004.1.283</div><div>6. Foucar E, Rosai J, Dorfman R. Sinus histiocytosis with massive
lymphadenopathy (Rosai-Dorfman disease): review of the entity.<i>Seminars in diagnostic pathology</i> . Feb 1990;7(1):19-73.</div><div>7. Komp DM. The treatment of sinus histiocytosis with massive
lymphadenopathy (Rosai-Dorfman disease). <i>Seminars in diagnostic
pathology</i> . Feb 1990;7(1):83-6.</div><div>8. Afzal M, Baez-Giangreco A, al Jaser AN, Onuora VC. Unusual bilateral
renal histiocytosis. Extranodal variant of Rosai-Dorfman disease.<i>Arch Pathol Lab Med</i> . 1992/12// 1992;116(12):1366-1367.</div><div>9. Kmetz DJ, Van Leeuwen B, Bentley D. Symptomatic Rosai-Dorfman Disease
Presenting as Isolated Bilateral Perinephric Infiltration. <i>Rev
Urol</i> . 2019 2019;21(1):41-44.</div><div>10. Bassa C, Tagle R, Claro E, Mendez G, Dominguez J.
Rosai-Dorfman-Destombes disease with renal involvement and secondary
glomerulopathy: Report of an exceptional case. <i>Urol Case Rep</i> .
2018;22:17-18. doi:10.1016/j.eucr.2018.10.004</div><div>11. El Majdoub A, El Houari A, Chbani L, El Fatemi H, Khallouk A, Farih
MH. Isolated localization of Rosai Dorfman disease as renal mass: a case
report and review of literature. <i>Pan Afr Med J</i> . 2016;24:64-64.
doi:10.11604/pamj.2016.24.64.6291</div><div>12. Gitsch G, Kohlberger P, Steiner A, Neumeister B, Breitenecker G.
Expression of cytokeratins in granulosa cell tumors and ovarian
carcinomas. <i>Archives of Gynecology and Obstetrics</i> . 1992/07/01
1992;251(4):193-197. doi:10.1007/BF02718386</div><div>13. Alexa A, Baderca F, Lighezan R, Izvernariu D, Raica M. The
diagnostic value of cytokeratins expression in the renal parenchyma
tumors. <i>Romanian journal of morphology and embryology = Revue
roumaine de morphologie et embryologie</i> . 2010;51(1):27-35.</div><div>14. Gumeler E, Onur MR, Karaosmanoglu AD, Ozmen M, Akata D,
Karcaaltincaba M. Computed tomography and magnetic resonance imaging of
peripelvic and periureteric pathologies. <i>Abdominal Radiology</i> .
2018/09/01 2018;43(9):2400-2411. doi:10.1007/s00261-017-1444-5</div><div>15. Albano D, Bosio G, Bertagna F. 18F-FDG PET/CT Follow-up of
Rosai-Dorfman Disease. 2015;40(8):e420-e422.
doi:10.1097/rlu.0000000000000853</div><div>16. Karaosmanoğlu AD, Onur MR, Shirkhoda A, Ozmen M, Hahn PF. Unusual
benign solid neoplasms of the kidney: cross-sectional imaging findings.<i>Diagn Interv Radiol</i> . 2015 Sep-Oct 2015;21(5):376-381.
doi:10.5152/dir.2015.14545</div><div>17. Abdollahi A, Ardalan FA, Ayati MJAoSm. Extranodal Rosai-Dorfman
disease of the kidney. 2009;29(1):55-57.</div><div>18. Bain ES, Kinney TB, Gooding JM, Casola G, Ysrael MZ. Sinus
histiocytosis with massive lymphadenopathy (Rosai-Dorfman Disease): a
rare cause of bilateral renal masses. <i>AJR American journal of
roentgenology</i> . Apr 1999;172(4):995-6. doi:10.2214/ajr.172.4.10587134</div><div>19. Brown WE, Coakley FV, Heaney MLJAI. Renal involvement by Rosai
Dorfman disease: CT findings. 2001;27:214-216.</div><div>20. Jian QY, Zhuang H, Xiu Y, Talati E, Alavi AJCnm. Demonstration of
increased FDG activity in Rosai-Dorfman disease on positron emission
tomography. 2004;29(3):209-210.</div><div>21. Shrestha R, Jamison DK, Anene D, Roarke M, Yang MJJoNM. The Role of
F18-FDG PETCT in the Evaluation and Surveillance of Rosai-Dorfman
Disease. 2020;61(supplement 1):1158-1158.</div><div>22. Karunanithi S, Singh H, Sharma P, Naswa N, Kumar RJCNM. 18F-FDG
PET/CT imaging features of Rosai Dorfman disease: a rare cause of
massive generalized lymphadenopathy. 2014;39(3):268-269.</div><div>23. Ng CS, Wood CG, Silverman PM, Tannir NM, Tamboli P, Sandler CM.
Renal cell carcinoma: diagnosis, staging, and surveillance. <i>AJR
American journal of roentgenology</i> . Oct 2008;191(4):1220-32.
doi:10.2214/ajr.07.3568</div><div>24. Sheth S, Scatarige JC, Horton KM, Corl FM, Fishman EK. Current
concepts in the diagnosis and management of renal cell carcinoma: role
of multidetector ct and three-dimensional CT. <i>Radiographics : a
review publication of the Radiological Society of North America, Inc</i> .
Oct 2001;21 Spec No:S237-54.
doi:10.1148/radiographics.21.suppl_1.g01oc18s237</div><div>25. Oliva MR, Glickman JN, Zou KH, et al. Renal cell carcinoma: t1 and
t2 signal intensity characteristics of papillary and clear cell types
correlated with pathology. <i>AJR American journal of roentgenology</i> .
Jun 2009;192(6):1524-30. doi:10.2214/ajr.08.1727</div><div>26. Ascenti G, Gaeta M, Magno C, et al. Contrast-enhanced
second-harmonic sonography in the detection of pseudocapsule in renal
cell carcinoma. <i>AJR American journal of roentgenology</i> . Jun
2004;182(6):1525-30. doi:10.2214/ajr.182.6.1821525</div><div>27. Purysko AS, Westphalen AC, Remer EM, Coppa CP, Filho HML, Herts BR.
Imaging Manifestations of Hematologic Diseases with Renal and
Perinephric Involvement. 2016;36(4):1038-1054. doi:10.1148/rg.2016150213</div><div>28. Sheth S, Ali S, Fishman E. Imaging of renal lymphoma: patterns of
disease with pathologic correlation. <i>Radiographics : a review
publication of the Radiological Society of North America, Inc</i> . Jul-Aug
2006;26(4):1151-68. doi:10.1148/rg.264055125</div><div>29. Urban BA, Fishman EK. Renal Lymphoma: CT Patterns with Emphasis on
Helical CT. 2000;20(1):197-212.
doi:10.1148/radiographics.20.1.g00ja09197</div><div>30. Ye XH, Chen LH, Wu HB, et al. 18F-FDG PET/CT evaluation of lymphoma
with renal involvement: comparison with renal carcinoma. <i>Southern
medical journal</i> . Jul 2010;103(7):642-9.
doi:10.1097/SMJ.0b013e3181e23cb0</div><div>31. Murray D, Marshall M, England E, Mander J, Chakera TM.
Erdheim-chester disease. <i>Clin Radiol</i> . 2001/06//
2001;56(6):481-484. doi:10.1053/crad.2001.0681</div><div>32. O’Rourke R, Wong D, Fleming S, Walker D. Erdheim–Chester disease: A
rare cause of acute renal failure. 2007;51(s1):B48-B51.
doi:10.1111/j.1440-1673.2007.01821.x</div><div>33. Mitnick JS, Bosniak MA, Rothberg M, Megibow AJ, Raghavendra BN,
Subramanyam BRJJocat. Metastatic neoplasm to the kidney studied by
computed tomography and sonography. 1985;9(1):43-49.</div><div>34. Zukotynski K, Lewis A, O’Regan K, et al. PET/CT and renal pathology:
a blind spot for radiologists? Part 2–lymphoma, leukemia, and
metastatic disease. <i>AJR American journal of roentgenology</i> . Aug
2012;199(2):W168-74. doi:10.2214/ajr.11.7923</div>